1 inhibited the proliferation of MLL-rearranged leukemia cells with EC50 values of 0.17–6.5 μM, while it showed significantly reduced activity against leukemia cells without a MLL rearrangement (EC50: 13.9–>50 μM). This evidence concerns the gene KMT2A and leukemia.